We have located links that may give you full text access.
Race distribution in non-arteritic anterior ischemic optic neuropathy.
American Journal of Ophthalmology 2023 March 23
PURPOSE: To describe the racial distribution of patients diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION) in two large urban academic centers in the United States (US).
DESIGN: Retrospective cross-sectional study.
METHODS: All NAION patients evaluated between 2014 and 2022 in tertiary neuro-ophthalmology services in Atlanta, GA and New York, NY, respectively, were included. In order to assess the racial accessibility to our services, similar numbers of idiopathic intracranial hypertension (IIH) patients seen in the same services were included. Self-reported race at the time of neuro-ophthalmologic examination was collected for all patients. Results were compared with data published by the US Bureau of Census for Decennial Census in 2020 for the states of Georgia and New York, and for the total population of the US.
RESULTS: In both locations, the vast majority of NAION patients reported being White (91.06% in Atlanta and 78.9% in New York). Only 7.27% of patients in Atlanta and 3% in New York reported being Black, and 1.24% of patients in Atlanta and 5.9% in New York reported being Asian. There was a much higher proportion of White people among NAION patients than in the group of IIH patients and in each respective state and in the US.
CONCLUSIONS: Our results show that the majority of NAION patients are White, followed by Black and Asian races, respectively, thus confirming the NAION race distribution reported by past clinical trials.
DESIGN: Retrospective cross-sectional study.
METHODS: All NAION patients evaluated between 2014 and 2022 in tertiary neuro-ophthalmology services in Atlanta, GA and New York, NY, respectively, were included. In order to assess the racial accessibility to our services, similar numbers of idiopathic intracranial hypertension (IIH) patients seen in the same services were included. Self-reported race at the time of neuro-ophthalmologic examination was collected for all patients. Results were compared with data published by the US Bureau of Census for Decennial Census in 2020 for the states of Georgia and New York, and for the total population of the US.
RESULTS: In both locations, the vast majority of NAION patients reported being White (91.06% in Atlanta and 78.9% in New York). Only 7.27% of patients in Atlanta and 3% in New York reported being Black, and 1.24% of patients in Atlanta and 5.9% in New York reported being Asian. There was a much higher proportion of White people among NAION patients than in the group of IIH patients and in each respective state and in the US.
CONCLUSIONS: Our results show that the majority of NAION patients are White, followed by Black and Asian races, respectively, thus confirming the NAION race distribution reported by past clinical trials.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app